Benedikte Hasselbalch – Research output — The Capital Region of Denmark's Research Portal

Research activity per year

10 Journal article
3 Book chapter
1 Ph.D. thesis
1 Review

10 results

Filter

2024
Immunotherapy drives mesenchymal tumor cell state shift and TME immune response in glioblastoma patients
Hendriksen, J. D., Locallo, A., Maarup, S., Debnath, O., Ishaque, N., Hasselbach, B., Skjøth-Rasmussen, J., Yde, C. W., Poulsen, H. S., Lassen, U. & Weischenfeldt, J., 5 Aug 2024, In: Neuro-Oncology. 26, 8, p. 1453-1466 14 p.
Research output: Contribution to journal › Journal article › Research › peer-review
Nivolumab reaches brain lesions in patients with recurrent glioblastoma and induces T-cell activity and upregulation of checkpoint pathways
Skadborg, S. K., Maarup, S., Draghi, A., Borch, A., Hendriksen, S., Mundt, F., Pedersen, V., Mann, M., Christensen, I. J., Skjøth-Rasmussen, J., Yde, C. W., Kristensen, B. W., Skovgaard Poulsen, H., Hasselbalch, B., Svane, I. M., Lassen, U. & Hadrup, S. R., 3 Sept 2024, In: Cancer immunology research. 12, 9, p. 1202-1220 19 p.
Research output: Contribution to journal › Journal article › Research › peer-review
2023
The Neurogenome study: Comprehensive molecular profiling to optimize treatment for Danish glioblastoma patients
Nørøxe, D. S., Maarup, S., Fougner, V., Muhic, A., Møller, S., Urup, T., Lü, M. J. S., Weischenfeldt, J., Hansen, A. E., Skovgaard Poulsen, H., Lassen, U. & Hasselbalch, B., 2023, In: Neuro-Oncology Advances. 5, 1, vdad137.
Research output: Contribution to journal › Journal article › Research › peer-review
2022
Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [F-18]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastoma
Henriksen, O. M., Hansen, A. E., Muhic, A., Marner, L., Madsen, K., Møller, S., Hasselbalch, B., Lundemann, M. J., Scheie, D., Skjøth-Rasmussen, J., Poulsen, H. S., Larsen, V. A., Larsson, H. B. W. & Law, I., Nov 2022, In: European Journal of Nuclear Medicine and Molecular Imaging. 49, 13, p. 4677-4691 15 p.
Research output: Contribution to journal › Journal article › Research › peer-review
6 Citations (Scopus)
2021
A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution
Abedi, A. A., Grunnet, K., Christensen, I. J., Michaelsen, S. R., Muhic, A., Møller, S., Hasselbalch, B., Poulsen, H. S. & Urup, T., 25 Feb 2021, In: Frontiers in Oncology. 11, p. 1-9 9 p., 597587.
Research output: Contribution to journal › Journal article › Research › peer-review
14 Citations (Scopus)
2013
Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme
Lassen, U., Sorensen, M., Gaziel, T. B., Hasselbalch, B. & Poulsen, H. S., Apr 2013, In: Anticancer Research. 33, 4, p. 1657-60 4 p.
Research output: Contribution to journal › Journal article › Research › peer-review
85 Citations (Scopus)
2011
Irinotecan and bevacizumab in recurrent glioblastoma multiforme
Jakobsen, J. N., Hasselbalch, B., Stockhausen, M.-T., Lassen, U. & Poulsen, H. S., 1 Apr 2011, In: Expert Opinion on Pharmacotherapy. 12, 5, p. 825-33 9 p.
Research output: Contribution to journal › Journal article › Research › peer-review
33 Citations (Scopus)
2010
Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial
Hasselbalch, B., Lassen, U., Hansen, S., Holmberg, M., Sørensen, M., Kosteljanetz, M., Broholm, H., Stockhausen, M.-T. & Poulsen, H. S., 1 May 2010, In: Neuro-Oncology. 12, 5, p. 508-16 9 p.
Research output: Contribution to journal › Journal article › Research › peer-review
198 Citations (Scopus)
Cetuximab insufficiently inhibits glioma cell growth due to persistent EGFR downstream signaling
Hasselbalch, B., Lassen, U., Poulsen, H. S. & Stockhausen, M.-T., 1 Oct 2010, In: Cancer Investigation. 28, 8, p. 775-87 13 p.
Research output: Contribution to journal › Journal article › Research › peer-review
20 Citations (Scopus)
Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan
Hasselbalch, B., Eriksen, J. G., Broholm, H., Christensen, I. J., Grunnet, K., Poulsen, H. S., Stockhausen, M.-T. & Lassen, U., 1 Aug 2010, In: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 118, 8, p. 585-94 10 p.
Research output: Contribution to journal › Journal article › Research › peer-review
41 Citations (Scopus)